Japan is legendary for its focus—many would say obsession—on producing high-quality products. When it comes to sourcing active pharmaceutical ingredients (APIs), Japanese generic drug firms are ...

Japan’s pharmaceutical industry is undergoing a period of transformation, and the contract development and manufacturing organization (CDMO) of large molecule active pharmaceutical ingredients (APIs) ...

Japan's government is looking to procure more generic drugs to help relieve its healthcare budget, and Eisai intends to cash in on that shift by offering its own India-made APIs to competitors. It is ...

Great news for Japanese developers: Twilio has been working with Japanese telecom giant KDDI, and today, the two entities are co-releasing a new API just for communications in Japan. Twilio for KWC* ...

The FDA slapped Japanese API maker Yuki Gosei Kogyo with a warning letter, citing the Tokyo-based company for failing to report lab testing data on released lots. The warning letter was in response to ...

Japan has a large, well-developed pharmaceutical market and offers universal health coverage to its citizens. The country has one of the most advanced research and development facilities across the ...

Twilio For KWC provides full access to Twilio's communications API platform, and the service features the underlying connectivity with Japanese domestic carriers provided by KWC. Developers and ...

Sai Life Sciences announced that the Japanese regulatory agency, Pharmaceuticals and Medical Devices Agency (PMDA) completed a paper-based compliance inspection of its intermediate & API manufacturing ...